What is (and what is not) a COPD exacerbation: thoughts from the new GOLD guidelines
- PMID: 17329557
- PMCID: PMC2117162
- DOI: 10.1136/thx.2007.077883
What is (and what is not) a COPD exacerbation: thoughts from the new GOLD guidelines
Abstract
Definition of what is (and what is not) a COPD exacerbation
Conflict of interest statement
Competing interests: None declared.
Similar articles
-
Review of guidelines and the literature in the treatment of acute bronchospasm in chronic obstructive pulmonary disease.Pharmacotherapy. 2006 Sep;26(9 Pt 2):156S-63S. doi: 10.1592/phco.26.9part2.156S. Pharmacotherapy. 2006. PMID: 16945062 Review.
-
Factors associated with hospital admission among emergency department patients with chronic obstructive pulmonary disease exacerbation.Acad Emerg Med. 2007 Jan;14(1):6-14. doi: 10.1197/j.aem.2006.07.034. Epub 2006 Nov 21. Acad Emerg Med. 2007. PMID: 17119187
-
Exacerbation of chronic obstructive pulmonary disease.Med J Malaysia. 2009 Sep;64(3):250-5; quiz 256. Med J Malaysia. 2009. PMID: 20527283 Review.
-
How should we manage an acute exacerbation of COPD?J Fam Pract. 2003 Oct;52(10):780-2. J Fam Pract. 2003. PMID: 14529602
-
Global initiative for chronic obstructive lung disease for chronic obstructive pulmonary disease: GOLD opportunity for lung disorders.Prev Med. 2005 Mar;40(3):274-7. doi: 10.1016/j.ypmed.2004.06.010. Prev Med. 2005. PMID: 15533539
Cited by
-
Evolution of the COPD Assessment Test score during chronic obstructive pulmonary disease exacerbations: determinants and prognostic value.Can Respir J. 2013 Sep-Oct;20(5):e92-7. doi: 10.1155/2013/398120. Can Respir J. 2013. PMID: 24093119 Free PMC article.
-
COPD exacerbation: lost in translation.BMC Pulm Med. 2009 Jan 29;9:6. doi: 10.1186/1471-2466-9-6. BMC Pulm Med. 2009. PMID: 19178701 Free PMC article.
-
Joint statement for the diagnosis, management, and prevention of chronic obstructive pulmonary disease for Gulf Cooperation Council countries and Middle East-North Africa region, 2017.Int J Chron Obstruct Pulmon Dis. 2017 Oct 9;12:2869-2890. doi: 10.2147/COPD.S136245. eCollection 2017. Int J Chron Obstruct Pulmon Dis. 2017. PMID: 29070946 Free PMC article. Review.
-
The Interplay Between Immune Response and Bacterial Infection in COPD: Focus Upon Non-typeable Haemophilus influenzae.Front Immunol. 2018 Nov 5;9:2530. doi: 10.3389/fimmu.2018.02530. eCollection 2018. Front Immunol. 2018. PMID: 30455693 Free PMC article. Review.
-
Effectiveness and Tolerability of LABA/LAMA Fixed-Dose Combinations Aclidinium/Formoterol, Glycopyrronium/Indacaterol and Umeclidinium/Vilanterol in the Treatment of COPD in Daily Practice - Results of the Non-Interventional DETECT Study.Int J Chron Obstruct Pulmon Dis. 2020 Jun 10;15:1335-1347. doi: 10.2147/COPD.S252354. eCollection 2020. Int J Chron Obstruct Pulmon Dis. 2020. PMID: 32606643 Free PMC article. Clinical Trial.
References
-
- Anon 2006 Global strategy for diagnosis, management, and prevention of COPD. www.goldcopd.com (accessed 17 January 2007)
-
- Debigare R, Cote C H, Maltais F. Peripheral muscle wasting in chronic obstructive pulmonary disease. Clinical relevance and mechanisms. Am J Respir Crit Care Med 20011641712–1717. - PubMed
-
- Biskobing D M. COPD and osteoporosis. Chest 2002121609–620. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical